Stock & Company Details
Novo-Nordisk A/S $NVO
Price:
46,691,331
3.4B
$212B
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
NVO technical indicators
Latest Novo-Nordisk A/S (NVO) technical indicators as of 2026-07-01: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
68.58 4.4%
MACD:
1.30 8.5%
SMA 50:
$44.26 0.4%
SMA 200:
$47.86 0.1%
EMA 20:
$45.90 0.7%
Bollinger Bands:
49.75 / 40.07
Stochastic:
92.33 1.9%
ADX 14:
21.71 6.2%
ATR 14:
1.34 1.5%
CCI 20:
126.89 4.7%
OBV:
-347.78M 3.1%
ROC 12:
11.14% 23.1%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Novo Nordisk (NVO) is a global healthcare leader focused on diabetes care, obesity treatments, and rare disease therapies. Headquartered in Denmark, the company develops innovative GLP-1 and insulin products that serve millions of patients worldwide. With strong growth driven by demand for weight-loss and metabolic treatments, NVO combines consistent revenue expansion, high margins, and significant investment in research and development.
Finance Bot
Ask your questions
Start by typing a question below.
